AlveoliX, Vitrocell, University of Bern, and Helmholtz Institute for Pharmaceutical Research Saarland published a study in Bioengineering & Translational Medicine on a stretchable human lung-on-chip model for alveolar inflammation, funded by Eurostars. The model mimics human lung function, enabling high-fidelity disease modeling and personalized drug testing, reducing animal testing. The collaboration led to Alexis Technologies, offering inhalation exposure systems with breathing Organs-on-Chip technology for various applications.